A literature review on off-label drug use in children
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Unlabelled The aim was to compare results of studies performed in different settings worldwide and identify common therapeutic areas to allow for focused interventions, because off-label drug use can be a measure of the lack of knowledge concerning paediatric treatments. A secondary objective was to provide a brief review of efforts to date. A literature review of articles on off-label and unlicensed drug use in children involving general prescription samples was performed using Medline and Embase. In all, 30 studies from 1985-2004 were included. Eleven involved paediatric hospital wards, seven neonatal hospital wards, and 12 the community setting. The off-label and unlicensed classification methods varied, making results difficult to compare. In general, off-label/unlicensed prescription rates ranged from 11%-80%, and higher rates were found in younger versus older patients and in the hospital versus community settings. On the paediatric hospital wards, off-label/unlicensed prescriptions ranged from 16%-62% and most often concerned acetaminophen, cisapride, chloral hydrate, and salbutamol. In the neonatal wards, rates ranged from 55%-80% and often involved caffeine. In the community setting, rates ranged from 11%-37% and the most commonly implicated drugs were salbutamol and amoxicillin.Conclusion A lack of harmonization between the evidence, the information available to doctors, and its use in clinical practice exists and this is part of the reason off-label therapies are so common. Attempts have been made to improve knowledge concerning paediatric treatments, but more focused interventions are needed, also taking into consideration this lack of harmonization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In most countries, paracetamol is the most used analgesic-antipyretic drug in children (21,158,179).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [158]
Citations
Cites
Survey of unlicensed and off label drug use in paediatric wards in European countries
Conroy, S. (2000) · BMJ · doi:10.1136/bmj.320.7227.79 · Cited by 735
Caldwell, P. H., Murphy, S. B., Butow, P. N., & Craig, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16942-0 · Cited by 490
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study
Turner, S., Nunn, A., Fielding, K., & Choonara, I. (1999) · Acta Paediatrica · doi:10.1080/08035259950168469 · Cited by 411
Unlicensed and off label drug use in paediatric wards: prospective study
Turner, S., Longworth, A., Nunn, A. J., & Choonara, I. (1998) · BMJ · doi:10.1136/bmj.316.7128.343 · Cited by 317
Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study
Turner, S. J., Nunn, A., Fielding, K., et al. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb00191.x · Cited by 314
Pediatric Drug Labeling: Improving the Safety and Efficacy of Pediatric Therapies
Roberts, R., Rodriguez, W., Murphy, D., & Crescenzi, T. (2003) · JAMA · doi:10.1001/jama.290.7.905 · Cited by 299
Adverse drug reactions and off-label drug use in paediatric outpatients
Horen, B., Montastruc, J.-L., & Lapeyre-Mestre, M. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.t01-3-01689.x · Cited by 294
Unlicensed and off label drug use in neonates
Conroy, S., McIntyre, J., & Choonara, I. (1999) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.80.2.f142 · Cited by 286
Unlicensed and off label prescribing of drugs in general practice
McIntyre, J. (2000) · Archives of Disease in Childhood · doi:10.1136/adc.83.6.498 · Cited by 234
Unlicensed and Off-Label Drug Use in Children: Implications for Safety
Choonara, I., & Conroy, S. (2002) · Drug Safety · doi:10.2165/00002018-200225010-00001 · Cited by 224
Testing Medications in Children
Steinbrook, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmhpr021646 · Cited by 207
The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients
Neubert, A., Dormann, H., Weiss, J., Egger, T., Criegee-Rieck, M., Rascher, W., Brune, K., & Hinz, B. (2004) · Drug Safety · doi:10.2165/00002018-200427130-00006 · Cited by 186
Off label and unlicensed drug use among French office based paediatricians
Chalumeau, M. (2000) · Archives of Disease in Childhood · doi:10.1136/adc.83.6.502 · Cited by 169
A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children's Hospital
't Jong, G. W., Vulto, A. G., de Hoog, M., Schimmel, K. J. M., Tibboel, D., & van den Anker, J. N. (2001) · Pediatrics · doi:10.1542/peds.108.5.1089 · Cited by 166
The British Medical Association in London
(1910) · Nature · doi:10.1038/084153a0 · Cited by 158
Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit
O’Donnell, C. P., Stone, R. J., & Morley, C. J. (2002) · PEDIATRICS · doi:10.1542/peds.110.5.e52 · Cited by 145
Use of "off-label" and unlicensed drugs in paediatric intensive care unit
Turner, S. C. M., Gill, A. M., Nunn, T., Hewitt, B., & Choonara, I. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91182-4 · Cited by 129
Off label prescribing to children in primary care in Germany: retrospective cohort study
Bücheler, R., Schwab, M. G., Mörike, K., Kalchthaler, B., Mohr, H., Schröder, H., Schwoerer, P., & Gleiter, C. H. (2002) · BMJ · doi:10.1136/bmj.324.7349.1311 · Cited by 125
Food and Drug Administration Modernization Act
(2004) · The Pharmaceutical Regulatory Process · doi:10.1201/9780203997048-9 · Cited by 118
Extemporaneous (magistral) preparation of oral medicines for children in European hospitals
Brion, F., Nunn, A., & Rieutord, A. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00583.x · Cited by 108
Hull, D., Choonara, I., Sammons, H. M., & Beresford, M. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-43582-4_18 · Cited by 100
Risk Factors for Unlicensed and Off-Label Drug Use in Children Outside the Hospital
Schirm, E., Tobi, H., & de Jong-van den Berg, L. T. W. (2003) · Pediatrics · doi:10.1542/peds.111.2.291 · Cited by 99
Unlicensed and off label prescription of drugs to children: population based cohort study
Jong, G. W. ‘., Eland, I. A., Sturkenboom, M., van den Anker, J. N., & Stricker, B. H. C. (2002) · BMJ · doi:10.1136/bmj.324.7349.1313 · Cited by 98
Uses of Drugs Not Described in the Package Insert (Off-Label Uses)
Committee on Drugs (2002) · PEDIATRICS · doi:10.1542/peds.110.1.181 · Cited by 96
Off-label use of drugs in Italy: a prospective, observational and multicentre study
Pandolfini, C., Impicciatore, P., Provasi, D., Rocchi, F., Campi, R., Bonati, M. R., & Italian Paediatric Off‐label Collaborative Group (2002) · Acta Paediatrica · doi:10.1080/08035250252834030 · Cited by 88
Self-citationBurns, J. P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000054905.39382.58 · Cited by 87
Unlicensed and Off-Label Medication Use in a Neonatal Intensive Care Unit: A Prospective Study
Barr, J., Brenner-Zada, G., Heiman, E., Pareth, G., Bulkowstein, M., Greenberg, R., & Berkovitch, M. (2002) · American Journal of Perinatology · doi:10.1055/s-2002-23557 · Cited by 82
Ufer, M., Kimland, E. E., & Bergman, U. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.858 · Cited by 81
Off-label prescribing to children in primary care: retrospective observational study
Ekins-Daukes, S., Helms, P., Simpson, C. R., Taylor, M. W., & McLay, J. S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0752-1 · Cited by 81
Public Registration of Clinical Trials
Steinbrook, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048191 · Cited by 77
Impicciatore, P., & Choonara, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00981.x · Cited by 75
Incidence des prescriptions hors autorisation de mise sur le marché en réanimation néonatale
Avenel, S., Bomkratz, A., Dassieu, G., Janaud, J. C., & Danan, C. (2000) · Archives de Pédiatrie · doi:10.1016/s0929-693x(00)88083-5 · Cited by 73
Dosing information for paediatric patients: are they really “therapeutic orphans”?
Tan, E., Rayner, C. R., Chapman, C. B., & Cranswick, N. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05498.x · Cited by 71
Adverse drug reactions in a paediatric intensive care unit
Gill, A., Leach, H., Hughes, J., Barker, C. E., Nunn, A., & Choonara, I. (1995) · Acta Paediatrica · doi:10.1111/j.1651-2227.1995.tb13667.x · Cited by 69
Making medicines that children can take
Nunn, A. J. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.5.369 · Cited by 69
A novel scheme for the reporting of adverse drug reactions
Clarkson, A. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.84.4.337 · Cited by 66
Unlicensed and Off-Label Drug Use: Issues and Recommendations
Conroy, S. (2002) · Pediatric Drugs · doi:10.2165/00128072-200204060-00002 · Cited by 63
Off‐label use of drugs in Italy: a prospective, observational and multicentre study
Pandolfini, C., Impicciatore, P., Provasi, D., et al. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb01726.x · Cited by 61
Self-citationUnlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
Gavrilov, V., Lifshitz, M., Levy, J., & Gorodischer, R. (2000) · PubMed · Cited by 54
Ufer, M., Rane, A., Karlsson, Å., Kimland, E. E., & Bergman, U. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0560-z · Cited by 53
Clinical investigation of medicinal products in the paediatric population
Eckstein, S. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511550089.060 · Cited by 52
Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products
Ceci, A., Felisi, M. G., Catapano, M., Baiardi, P., Cipollina, L., Ravera, S., Bagnulo, S., Reggio, S., & Rondini, G. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0511-0 · Cited by 45
Dick, A., Keady, S., Mohamed, F. M., Brayley, S., Thomson, M. A., Lloyd, B. W., Heuschkel, R. B., & Afzal, N. A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01441.x · Cited by 44
Use of unlabelled and off licence drugs in children
Riordan, F. A. I. (2000) · BMJ · doi:10.1136/bmj.320.7243.1210 · Cited by 43
Prescription medicine use by one million Canadian children
Khaled, L. A., Ahmad, F., Brogan, T., Fearnley, J., Graham, J., MacLeod, S. M., & McCormick, J. (2001) · Paediatrics & Child Health · doi:10.1093/pch/8.suppl_a.6a · Cited by 38
Extemporaneous (magistral) preparation of oral medicines for children in European hospitals
Conroy, S. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00568.x · Cited by 36
Determinants for drug prescribing to children below the minimum licensed age
Jong, G. W. ‘., Eland, I. A., Sturkenboom, M., van den Anker, J. N., & Stricker, B. H. C. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0554-2 · Cited by 33
Unregistered and Off‐Label Drug Use in Paediatric Inpatients
Turner, S. C. M. (1999) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr1999295265 · Cited by 32
McKinzie, J. P., Wright, S. W., & Wrenn, K. D. (1997) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(97)90079-6 · Cited by 31
The Use of Drugs for Unlabeled Indications
Erickson, S. H. (1980) · JAMA · doi:10.1001/jama.1980.03300410031020 · Cited by 31
Intravenous immune globulin use in Canada.
Hanna, K., Poulin-Costello, M., Preston, M., & Maresky, N. (2003) · PubMed · Cited by 31
Craig, J. S., Henderson, C. R., & Magee, F. A. (2001) · PubMed · Cited by 31
Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients
Thompson, D. F., & Heflin, N. R. (1987) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/44.4.792 · Cited by 27
Unlicensed and off label drug use for paediatric patients
Martin, R. M., Wilton, L., Mann, R. D., Steventon, P., & Hilton, S. R. (1998) · BMJ · doi:10.1136/bmj.317.7152.204 · Cited by 26
Lack of effect of the European guidance on clinical investigation of medicines in children
de Jong, G. J., Strieker, B. H. C., Choonara, I., & van den Anker, J. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb00134.x · Cited by 26
Unlicensed and off-label drug use in elderly people
Hames, A. (2001) · Age and Ageing · doi:10.1093/ageing/30.6.530-a · Cited by 21
Launch of a European paediatric clinical trials register
Bonati, M. R., Pandolfini, C., Rossi, V., Santoro, E., Arnau, J. M., Danés, I., Camps, I., Castel, J. M., Jacqz-Aigrain, É., Zarrabian, S., et al. (2004) · Paediatric and Perinatal Drug Therapy · doi:10.1185/146300904x2425 · Cited by 20
Self-citationOff-Label Use of Approved Drugs
Bennett, W. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000118323.41076.01 · Cited by 19
Changing Requirements for Evaluation of Pharmacologic Agents
Chesney, R. W., & Christensen, M. L. (2004) · PEDIATRICS · doi:10.1542/peds.113.s3.1128 · Cited by 18
Unapproved prescription practices in primary pediatric clinics in Israel: A prospective analysis
Lifshitz, M., Gavrilov, V., Grossman, Z., Binsthok, M., Hornik, D., Rosemblum, H., Chemni, S., Alkrinawi, S., Miron, D., & Gorodischer, R. (2002) · Current Therapeutic Research · doi:10.1016/s0011-393x(02)80087-x · Cited by 17
Unapproved prescriptions in two pediatric intensive care units in Israel
Gavrilov, V., Berkovitch, M., Ling, G., Brenner-Zada, G., Lifshitz, M., & Gorodischer, R. (2003) · Current Therapeutic Research · doi:10.1016/j.curtheres.2003.09.016 · Cited by 17
Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy
Wilton, L., Stephens, M. D. B., & Mann, R. D. (1999) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199904)8:1+<s37::aid-pds400>3.0.co;2-9 · Cited by 17
Open access to industry's clinically relevant data
Herxheimer, A. (2004) · BMJ · doi:10.1136/bmj.329.7457.64 · Cited by 16
Congress, the FDA, and the Fair Development of New Medications for Children
McKinney, R. E. (2003) · PEDIATRICS · doi:10.1542/peds.112.3.669 · Cited by 15
Thouvenel, C., Gény, M. S., Demirdjian, S., & Vassal, G. (2002) · Archives de Pédiatrie · doi:10.1016/s0929-693x(01)00966-6 · Cited by 13
Is it time for a European formulary of paediatric medicines?
Bonati, M. R. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.048025 · Cited by 12
Self-citationUnlicensed and off-label use of psychotropic medications in French children: a prospective study
Serreau, R., Heuzey, M. L., Gilbert, A., Mouren, M., & Jacqz-Aigrain, É. (2004) · Paediatric and Perinatal Drug Therapy · doi:10.1185/146300904125004155 · Cited by 11
Unlicensed and Off-label Prescription of Systemic Anti-infective Agents to Children
Jong, G. W. ‘., Eland, I. A., de Hoog, M., Sturkenboom, M., van den Anker, J. N., & Stricker, B. H. C. (2002) · Paediatric and Perinatal Drug Therapy · doi:10.1185/146300902322125929 · Cited by 10
Lancet, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03147-0 · Cited by 9
Off-Label Drug Use in Children in Europe
Pandolfini, C., & Bonati, M. R. (2003) · Pharmaceutical Development and Regulation · doi:10.1007/bf03257372 · Cited by 8
Self-citationGuida all’uso dei farmaci per i bambini
Martini, N. G. D. L. E., Bonati, M. R., Pandolfini, C., Raschitelli, N., Rossi, L., Farina, L., Bacis, G., Grandori, L., Zanfi, D., Miselli, M., et al. (2003) · Ricerca & Pratica · Cited by 7
Self-citationWhere physicians look for information on drug prescribing for children
Matsui, D. M., Jardine, M. E., Steer, E., Cukernik, V., & Rieder, M. J. (2003) · Paediatrics & Child Health · doi:10.1093/pch/8.4.219 · Cited by 6
[Use of unlicensed and off-label drugs in hospitalized children].
Lifshitz, M., Gavrilov, V., & Gorodischer, R. (1999) · PubMed · Cited by 6
Use of "Off-Label" and Unlicensed Drugs in Neonatal and Paediatric Intensive Care in France
Tréluyer, J., Berger, J.-F., Leclerc, F., Lequien, P., Moriette, G., Hubert, P., & Pons, G. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-00281 · Cited by 4
Unlabeled Drug Use Patterns in a Contemporary Outpatient Setting
Serradell, J. (1991) · Journal of Pharmacoepidemiology · doi:10.1300/j055v02n02_03 · Cited by 4
(2000) · PubMed · Cited by 2
Research works printed but not linked: 6
- Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C (2000) The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr: 143–147
- Department of Health and Human Services, United States Food and Drug Administration (1994) Specific requirements on content and format of labeling for human prescription drugs; revision of the “pediatric use’ subsection in the labeling. Federal Register 59: 64240
- Kleist P (2002) Authorities recognize a need to encourage pediatric drug development. Applied Clinical Trials 11: 408
- Pandolfini C, Bonati M, Giozani M, Raffaelli MP, Rossi R, Serra G, Joppi R, Temporin G (2003) Off-label and unlicensed drug use in neonatal wards of three different Italian hospitals (abstract). Paed Perinat Drug Ther 5: 169
- Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients (1998) Federal Register 63: 66632
- Wilton LV, Pearce G, Mann RD (1999) The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Safety 8: S37–S45 · doi:10.1002/(sici)1099-1557(199904)8:1+<s37::aid-pds400>3.3.co;2-0
Cited by
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
“In most countries, paracetamol is the most used analgesic-antipyretic drug in children (21,158, 179).”
BackgroundBeasley, R., Clayton, T., Crane, J., von Mutius, E., Lai, C. K., Montefort, S., & Stewart, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61445-2 · Cited by 436
Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity
Ghanem, C. I., Pérez, M. J., Manautou, J. E., & Mottino, A. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.020 · Cited by 384
Pediatric Drug Formulations: A Review of Challenges and Progress
Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K. (2014) · Pediatrics · doi:10.1542/peds.2013-3225 · Cited by 324
Medication Use in the Neonatal Intensive Care Unit
Hsieh, E., Hornik, C., Clark, R., Laughon, M., Benjamin, D., Smith, P., & on Behalf of the Best Pharmaceuticals for Children Act—Pediatric Trials Network (2013) · American Journal of Perinatology · doi:10.1055/s-0033-1361933 · Cited by 318
Metadata
- Authors
- Pandolfini, C., & Bonati, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Pandolfini, Chiara
- Venue
- European Journal of Pediatrics
- Published
- 2005-05-24
- Volume
- 164
- Issue
- 9
- Pages
- 552-558
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W1995444135
- Cited by
- 346
- References
- 74
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 16 · 2021: 18 · 2020: 14 · 2019: 22 · 2018: 19 · 2017: 15 · 2016: 20 · 2015: 32 · 2014: 25 · 2013: 20 · 2012: 31
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- off-label drug use, unlicensed drug use, pediatric prescribing, children, neonates, hospital wards, community prescribing, paracetamol, cisapride, chloral hydrate, salbutamol, caffeine, amoxicillin, knowledge-practice gap, therapeutic areas
- MeSH terms
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Community Health Services, Drug Labeling, Hospitals, Pediatric, Humans, Infant, Infant, Newborn, Legislation, Drug, Drug Prescriptions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.